Date: 16th June, 2026
Acquisition / Strategic Actions
Marksans Pharma Limited has completed the acquisition of 100% share capital of QliniQ B.V., a company based in the Netherlands. This acquisition follows the company's prior intimation to the exchanges dated 1st June 2026. The transaction represents a full acquisition of the Dutch entity.